The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Sanchez Ramiro

Reporting owner CIK 0001830326 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline & trade size

Choose a reporting owner, transaction period, and security. Open any point for the filing.

Purchases in this page1
Other acquisitions0
Reporting owners1
SalesNot providedCheck original SEC filings

Oct 23, 2026 – Oct 23, 2026 · Transaction dates · Current page sample

Reported quantity · security units

Rapport Therapeutics, Inc. · Common Stock · Purchase (code P) · Non-derivative · Currency not specified

Reported transaction sizes by transaction dateEach point is one transaction for the selected company, security, and acquisition type. Reporting owners, exact quantities, and values are also provided in the table. These are filing amounts, not a stock-price series.3,6000Rapport Therapeutics, Inc. · Sanchez Ramiro (Director) · Purchase · October 23, 2026 · Quantity 3,600 · Price 27.3549 · Reference value 98,477.64 · Currency not specifiedOct 23, 2026Oct 23, 2026No reported values to plot for this selection.

Swipe the chart to see the full date range. Exact records are available in the table below.

1 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

1 dated transactions in this page sample · 1 reporting owners.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition typeQuantityPriceReference valueCurrency
Oct 23, 2026Rapport Therapeutics, Inc.Common StockSanchez Ramiro (Director)Purchase3,60027.354998,477.64Currency not specified

Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Rapport Therapeutics, Inc.RAPP · company listingsPurchaseCommon StockNon-derivative security · Code P3,60027.3549 *Value: 98,477.64Currency not specifiedView ↗